CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-17 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,721 | $69.01 | $602K | 496,965 |
| 2026-09-17 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,279 | $69.57 | $89K | 495,686 |
| 2026-08-19 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,100 | $83.86 | $679K | 507,586 |
| 2026-08-19 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,800 | $84.69 | $152K | 505,786 |
| 2026-08-19 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −100 | $85.65 | $9K | 505,686 |
| 2026-08-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,900 | $81.15 | $154K | 276,407 |
| 2026-08-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −17,279 | $82.21 | $1.4M | 259,128 |
| 2026-08-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −14,602 | $82.99 | $1.2M | 244,526 |
| 2026-08-18 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,199 | $83.77 | $100K | 243,327 |
| 2026-08-16 | Kumar Neil Chief Executive Officer | Option exercise | +33,544 | 276,871 | ||
| 2026-08-16 | Kumar Neil Chief Executive Officer | Option exercise | +19,599 | 296,470 | ||
| 2026-08-16 | Kumar Neil Chief Executive Officer | Option exercise | +11,554 | 308,024 | ||
| 2026-08-16 | Kumar Neil Chief Executive Officer | Option exercise | +6,520 | 314,544 | ||
| 2026-08-16 | Kumar Neil Chief Executive Officer | Shares withheld for taxes | −36,237 | $79.86 | $2.9M | 278,307 |
| 2026-08-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −33,544 | 67,088 | ||
| 2026-08-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −19,599 | 117,596 | ||
| 2026-08-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −11,554 | 115,538 | ||
| 2026-08-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −6,520 | 91,274 | ||
| 2026-06-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −7,147 | $67.20 | $480K | 528,539 |
| 2026-06-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,437 | $67.88 | $573K | 520,102 |
Page 1 of 10 · 196 trades